USA – Accelerated approval trials: Commenters seek details on single-arm considerations

The US Food and Drug Administration (FDA) aimed to address some of the criticisms of its accelerated approval program with new draft guidance that...

USA – FDA finalizes drug-drug interaction guidance for therapeutic proteins

The US Food and Drug Administration (FDA) on Friday issued a final guidance to assist sponsors in determining whether to conduct drug-drug interaction studies...

USA – FDA issues draft guidance on developing migraine prevention drugs

The US Food and Drug Administration (FDA) on Thursday released a draft guidance to help sponsors develop drugs to prevent migraines that offers recommendations...

USA – FDA considers new efficacy endpoint for diabetes drugs

The US Food and Drug Administration (FDA) on Friday released an updated draft guidance to help sponsors demonstrate efficacy for new antidiabetic drugs and...

UK – NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks

The National Institute for Care and Excellence (NICE) has announced that it has recommended an oral treatment for the prevention of episodic migraines for...

USA – FDA finalizes guidance on adjusting for covariates in randomized trials

The US Food and Drug Administration (FDA) on Friday released a final guidance addressing how sponsors can adjust for covariates in analyzing randomized clinical...

USA – FDA proposes long-awaited patient medication information rule

The US Food and Drug Administration (FDA) has proposed new drug labeling requirements to make it easier for patients to understand their medication while...

Europe – Global regulators agree on way forward to adapt COVID-19 vaccines to emerging...

International regulators have published a report today highlighting the outcomes of their discussions on COVID-19 vaccines and the need for and strategy to update their composition...

Europe – EU regulator recommends revoking approval for Novartis’ sickle cell disease drug

The European Medicines Agency’s (EMA) human medicines committee has recommended revoking the conditional marketing authorisation for Novartis’ sickle cell disease (SCD) drug Adakveo (crizanlizumab). The...

USA – FDA final guidance clarifies whole slide imaging expectations in nonclinical toxicology studies

The US Food and Drug Administration (FDA) on Tuesday issued final guidance on the use of whole slide imaging in nonclinical toxicology studies. The...

NOS PROCHAINES FORMATIONS